Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease

PLoS ONE

Volumn 3, Issue 12, 2008, Pages

  Spronk, Sandra ^a   Bosch, Johanna L ^a   Ryjewski, Constance ^b   Rosenblum, Judith ^b   Kaandorp, Guido C ^a   White, John V ^b,d   Hunink, M G Myriam ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEART REHABILITATION; HUMAN; MAJOR CLINICAL STUDY; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; REVASCULARIZATION; TREATMENT PLANNING; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH; MALE; MIDDLE AGED; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UNITED STATES;

CORONARY ARTERY DISEASE; COST-BENEFIT ANALYSIS; HEALTH; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UNITED STATES;

EID: 57549085130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003883     Document Type: Article

References (60)

1. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, et al. (2006) ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic InterSociety Consensus; and Vascular Disease Foundation. Circulation 113: e463-654.
2. Leon AS. Available: http://www.preventdisease.com/news/articles/ 012505_doctors_push_cardiac_programs.shtml. Accessed 2008 November 2.
3. Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, et al. (1998) Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med 339: 12-20.
4. Sanderson BK, Southard D, Oldridge N (2004) AACVPR consensus statement. Outcomes evaluation in cardiac rehabilitation/secondary prevention programs: improving patient care and program effectiveness. J Cardiopulm Rehabil 24: 68-79.
5. Poredos P, Jug B (2007) The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology 58: 309-315.
6. Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, et al. (2007) Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 116: 1653-1662.
7. Spronk S (Thesis; ISBN: 978-90-9022582-1. 2008) Management of patients with intermittent claudication. Rotterdam: Erasmus University.
8. Smith GD, Shipley MJ, Rose G (1990) Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 82: 1925-1931.
9. Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, et al. (1996) Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 25: 1172-1181.
10. Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: a practical guide. Med Decis Making 13: 322-338.
11. Hunink M, Glasziou P (2001) Decision making in health and medicine- Integrating evidence and values.; Press CU, editor. Cambridge.
12. Lenzen M, Scholte Op Reimer W, Norekval T, De Geest S, Fridlund B, et al. (2006) Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization Results from the Euro Heart Survey on Coronary Revascularization. Eur J Cardiovasc Nurs.
13. Yu CM, Lau CP, Chau J, McGhee S, Kong SL, et al. (2004) A short course of cardiac rehabilitation program is highly cost effective in improving long-term quality of life in patients with recent myocardial infarction or percutaneous coronary intervention. Arch Phys Med Rehabil 85: 1915-1922.
14. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP (1994) Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 14: 71-81.
15. Bergqvist D, Troeng T, Elfstrom J, Hedberg B, Ljungstrom KG, et al. (1998) Auditing surgical outcome: ten years with the Swedish Vascular Registry- Swedvasc. The Steering Committee of Swedvasc. Eur J Surg Suppl. pp 3-8.
16. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, et al. (2004) Exercisebased rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116: 682-692.
17. de Vries SO, Visser K, de Vries JA, Wong JB, Donaldson MC, et al. (2002) Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology 222: 25-36.
18. Bosch JL, van der Graaf Y, Hunink MG (1999) Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation 99: 3155-3160.
19. Bosch JL, Hunink MG (1997) Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 204: 87-96.
20. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, et al. (1995) Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. Jama 274: 165-171.
21. Prager MR, Hoblaj T, Nanobashvili J, Sporn E, Polterauer P, et al. (2003) Collagen- versus gelatine-coated Dacron versus stretch PTFE bifurcation grafts for aortoiliac occlusive disease: long-term results of a prospective, randomized multicenter trial. Surgery 134: 80-85.
22. Hessel SJ, Adams DF, Abrams HL (1981) Complications of angiography. Radiology 138: 273-281.
23. Waugh JR, Sacharias N (1992) Arteriographic complications in the DSA era. Radiology 182: 243-246.
24. Muradin GS, Bosch JL, Stijnen T, Hunink MG (2001) Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221: 137-145.
25. Gentile AT, Lee RW, Moneta GL, Taylor LM, Edwards JM, et al. (1996) Results of bypass to the popliteal and tibial arteries with alternative sources of autogenous vein. J Vasc Surg 23: 272-279; discussion 279-280.
26. Green RM, Abbott WM, Matsumoto T, Wheeler JR, Miller N, et al. (2000) Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 31: 417-425.
27. Johnson WC, Lee KK (2000) A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 32: 268-277.
28. Albers M, Battistella VM, Romiti M, Rodrigues AA, Pereira CA (2003) Metaanalysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 37: 1263-1269.
29. Tetteroo E, van der Graaf Y, Bosch JL, van Engelen AD, Hunink MG, et al. (1998) Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 351: 1153-1159.
30. Dugmore LD, Tipson RJ, Phillips MH, Flint EJ, Stentiford NH, et al. (1999) Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme. Heart 81: 359-366.
31. Russell MW, Huse DM, Drowns S, Hamel EC, Hartz SC (1998) Direct medical costs of coronary artery disease in the United States. Am J Cardiol 81: 1110-1115.
32. Bosch JL, Tetteroo E, Mali WP, Hunink MG (1998) Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group. Radiology 208: 641-648.
33. Jansen RM, de Vries SO, Cullen KA, Donaldson MC, Hunink MG (1998) Costidentification analysis of revascularization procedures on patients with peripheral arterial occlusive disease. J Vasc Surg 28: 617-623.
34. Wittels EH, Hay JW, Gotto AM Jr (1990) Medical costs of coronary artery disease in the United States. Am J Cardiol 65: 432-440.
35. Statistics DNCfH. Available: http://wwwcdcgov/nchs/datawh/statab/unpubd/ mortabshtm Accessed 2005 August 5.
36. Schweikert B, Hahmann H, Leidl R (2006) Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart 92: 62-67.
37. Tsevat J, Goldman L, Lamas GA, Pfeffer MA, Chapin CC, et al. (1991) Functional status versus utilities in survivors of myocardial infarction. Med Care 29: 1153-1159.
38. Chang RW, Goodney PP, Baek JH, Nolan BW, Rzucidlo EM, et al. (2008) Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg 48: 362-367.
39. Conrad MF, Cambria RP, Stone DH, Brewster DC, Kwolek CJ, et al. (2006) Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 44: 762-769.
40. Davidovic L, Vasic D, Maksimovic R, Kostic D, Markovic D, et al. (2004) Aortobifemoral grafting: factors influencing long-term results. Vascular 12: 171-178.
41. DeRubertis BG, Faries PL, McKinsey JF, Chaer RA, Pierce M, et al. (2007) Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg 246: 415-422; discussion 422-414.
42. Murphy TP, Ariaratnam NS, Carney WI Jr, Marcaccio EJ, Slaiby JM, et al. (2004) Aortoiliac insufficiency: long-term experience with stent placement for treatment. Radiology 231: 243-249.
43. Reed AB, Conte MS, Donaldson MC, Mannick JA, Whittemore AD, et al. (2003) The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. J Vasc Surg 37: 1219-1225.
44. Schanzer A, Hevelone N, Owens CD, Beckman JA, Belkin M, et al. (2008) Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg 47: 774-781.
45. Scott EC, Biuckians A, Light RE, Burgess J, Meier GH 3rd, et al. (2008) Subintimal angioplasty: Our experience in the treatment of 506 infrainguinal arterial occlusions. J Vasc Surg.
46. Fowkes FG (1988) The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 17: 248-254.
47. Statistics BoL. Available: http://www.bls.gov/oes/current/ oes_il.htm#b00-0000. Accessed 2006 June 25.
48. Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, et al. (1997) Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics 11: 159-168.
49. Weinstein MC, Stason WB (1977) Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 296: 716-721.
50. Stinnett AA, Mullahy J (1998) Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 18: S68-80.
51. Graham JD, Corso PS, Morris JM, Segui-Gomez M, Weinstein MC (1998) Evaluating the cost-effectiveness of clinical and public health measures. Annu Rev Public Health 19: 125-152.
52. Azimi NA, Welch HG (1998) The effectiveness of cost-effectiveness analysis in containing costs. J Gen Intern Med 13: 664-669.
53. Claxton K (1999) The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 18: 341-364.
54. Briggs AH, Goeree R, Blackhouse G, O'Brien BJ (2002) Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 22: 290-308.
55. Claxton K, Sculpher M, Drummond M (2002) A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet 360: 711-715.
56. Evenson KR, Fleury J (2000) Barriers to outpatient cardiac rehabilitation participation and adherence. J Cardiopulm Rehabil 20: 241-246.
57. Melnyk KA (1988) Barriers: a critical review of recent literature. Nurs Res 37: 196-201.
58. Tirrell BE, Hart LK (1980) The relationship of health beliefs and knowledge to exercise compliance in patients after coronary bypass. Heart Lung 9: 487-493.
59. Busschbach JJ, McDonnell J, Essink-Bot ML, van Hout BA (1999) Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D. J Health Econ 18: 551-571.
60. Morgan MB, Crayford T, Murrin B, Fraser SC (2001) Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg 33: 679-687.